Changes

|-

| September 28 || Scientific development (treatment) || Two papers from the Malaria Research Institute at the {{w|Johns Hopkins Bloomberg School of Public Health}} report promising strategies against malaria, one having discovered a strain of bacteria that can spread rapidly and persist long-term among malaria-carrying mosquitoes. A genetically modified version of that strain strongly suppresses development of the malaria parasite, making the mosquitoes much less likely to transmit these parasites to humans. A second study shows that a genetic modification that boosted the immune system of malaria-carrying mosquitoes not only suppresses malaria parasites in the insects but also can spread quickly. The findings are expected to lead the development of bacteria and mosquitoes that would be released into mosquito populations in the wild, then propagate on their own to reduce malaria transmission to humans in endemic areas.<ref>{{cite web |title=Two Ways of Making Malaria-Proof Mosquitoes |url=https://www.theatlantic.com/science/archive/2017/09/two-ways-of-making-malaria-proof-mosquitoes/541407/ |website=theatlantic.com |accessdate=17 December 2018}}</ref><ref>{{cite web |title=Promising results seen for two genetic weapons against malaria |url=https://hub.jhu.edu/2017/09/28/malaria-transmission-studies/ |website=hub.jhu.edu |accessdate=17 December 2018}}</ref> || {{w|Unitd States}}

|-

| October 26 || Scientific development || Researchers at the {{w|National Institutes of Health}} identify new targets for anti-malaria drugs, and show that the deadliest malaria parasite needs two proteins to infect red blood cells and exit the cells after it multiplies.<ref>{{cite web |title=NIH study identifies new targets for anti-malaria drugs |url=https://www.nih.gov/news-events/news-releases/nih-study-identifies-new-targets-anti-malaria-drugs |website=nih.gov |accessdate=18 December 2018}}</ref> || {{w|United States}}